PharmaShots | Incisive News in 3 Shots

Subscribe Now

Guardant360 CDx

PharmaShots Interview: Guardant Health's Justin Odegaard Shares Insight on the US FDA's Approval of Guardant360 CDx for Amgen's Lumakras

PharmaShots Interview: Guardant Health's Justin Odegaard Shares Insight on the US FDA's Approval of Guardant360 CDx for Amgen's Lu...

July 29, 2021

The US FDA Approves Guardant360 CDx as the First Liquid Biopsy NGS Assay to Identify EGFR Mutations in Non-Small Cell Lung Cancer

The US FDA Approves Guardant360 CDx as the First Liquid Biopsy NGS Assay to Identify EGFR Mutations in Non-Small Cell Lung Cancer

August 10, 2020

Contact Us

First Floor, B-66, Sector 63 Noida, Uttar Pradesh, INDIA - 201301
+91-120 428 0707
connect@pharmashots.com
Newsletter

Our Information

Follow Us